These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 32972460)
1. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway. Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis. Wen H; Liu Y; Li J; Wei D; Liu D; Zhao F Clin Exp Rheumatol; 2018; 36(5):798-805. PubMed ID: 29465363 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096 [TBL] [Abstract][Full Text] [Related]
4. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038 [TBL] [Abstract][Full Text] [Related]
5. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478 [TBL] [Abstract][Full Text] [Related]
6. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim HR; Kim BM; Cho ML; Lee SH Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732 [TBL] [Abstract][Full Text] [Related]
7. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis. Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926 [TBL] [Abstract][Full Text] [Related]
11. N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis. Kim HR; Kim KW; Kim BM; Lee KA; Lee SH Korean J Intern Med; 2019 Jan; 34(1):210-219. PubMed ID: 28286938 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways. Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes. Lee SY; Yoon BY; Kim JI; Heo YM; Woo YJ; Park SH; Kim HY; Kim SI; Cho ML Immunology; 2014 Mar; 141(3):353-61. PubMed ID: 24708416 [TBL] [Abstract][Full Text] [Related]
14. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. Park MK; Her YM; Cho ML; Oh HJ; Park EM; Kwok SK; Ju JH; Park KS; Min DS; Kim HY; Park SH Immunol Lett; 2011 Sep; 139(1-2):42-51. PubMed ID: 21620893 [TBL] [Abstract][Full Text] [Related]
15. DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis. Min HK; Kim SH; Lee JY; Lee SH; Kim HR Sci Rep; 2022 Jul; 12(1):12767. PubMed ID: 35896699 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358 [TBL] [Abstract][Full Text] [Related]
17. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Lee HY; Jeon HS; Song EK; Han MK; Park SI; Lee SI; Yun HJ; Kim JR; Kim JS; Lee YC; Kim SI; Kim HR; Choi JY; Kang I; Kim HY; Yoo WH Arthritis Rheum; 2006 Jun; 54(6):1747-58. PubMed ID: 16736517 [TBL] [Abstract][Full Text] [Related]
18. CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway. Li CH; Xu LL; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Yang L; Xing R; Liu XY Inflamm Res; 2016 Mar; 65(3):193-202. PubMed ID: 26621504 [TBL] [Abstract][Full Text] [Related]
19. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184 [TBL] [Abstract][Full Text] [Related]
20. Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis. Kim HR; Kim BM; Won JY; Lee KA; Ko HM; Kang YS; Lee SH; Kim KW J Med Food; 2019 Feb; 22(2):152-161. PubMed ID: 30596535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]